Implementing Business Practice: Instigating a Digital Interaction Evaluation Plan in Real Life
In the dynamic world of biopharmaceuticals, enhancing digital engagement, vendor auditing, and spending allocation has become crucial. This is where the expertise of data and analytics consulting services, such as those offered by Clarkston, can make a significant difference.
A recent case study demonstrates the effectiveness of Clarkston's services, as a biopharmaceutical company specializing in rare cancers partnered with them to develop a Digital Engagement Measurement Program. The program aimed to improve vendor auditing, leading to the identification of tens of millions of dollars of ineffective spending, significantly benefiting the client's digital measurement capabilities.
The Digital Engagement Measurement Program was designed to align business and technical needs, clarify campaign objectives, and structure analytics processes. Business translation consultants acted as intermediaries, ensuring that digital engagement metrics were both meaningful and actionable. Data analytics consulting enabled automated analysis across multiple channels, allowing for predictive insights and the identification of successful engagement strategies.
Clarkston's services also enhanced reporting and transparency. By generating internal reports, clients can independently validate vendor performance, reducing reliance on potentially biased external data and increasing accountability. Automated data pipelines supported by analytics platforms ensure that all vendor metrics are captured, standardized, and auditable, making it easier to detect discrepancies or inefficiencies.
Moreover, the services provided by Clarkston enabled data-driven decision making. By optimizing spend and measuring ROI, companies can re-evaluate and direct resources towards the most effective initiatives. The client's goal is to thoroughly assess metrics and corroborate vendors' reports, ensuring that spending is aligned with measurable outcomes.
In summary, by leveraging both business translation and data analytics consulting, biopharmaceutical companies can achieve greater transparency, improved efficiency, and more effective digital engagement strategies. Clarkston helped the client design and execute a scalable process, resulting in increased visibility into programs and vendors. To learn more about this case study, contact Clarkston below.
| Area | Business Translation Role | Data Analytics Consulting Role | |-----------------------------|------------------------------------------------|--------------------------------------------------| | Digital Engagement | Aligns business and tech, clarifies objectives | Automated analysis, predictive insights | | Vendor Auditing | Clarifies reporting needs, standardizes data | Internal reporting, validation, transparency | | Spending Allocation | Ensures alignment with business priorities | Optimizes spend, measures ROI, scales success |
[1] Source: Clarkston Consulting [2] Source: Gartner [3] Source: Forrester [4] Source: McKinsey & Company [5] Source: Deloitte
- In the realm of biopharmaceuticals, Clarkston's data and analytics consulting services have been instrumental in streamlining digital engagement, vendor auditing, and spend allocation, as demonstrated by a recent case study.
- The Digital Engagement Measurement Program, developed in collaboration with Clarkston, aimed to improve vendor auditing and clarify campaign objectives, resulting in the identification of tens of millions of dollars of ineffective spending.
- Clarkston's services extended beyond data analytics, offering business translation consultants who acted as intermediaries, ensuring that digital engagement metrics were meaningful and actionable.
- By optimizing spend and measuring return on investment, Clarkston's services enable data-driven decision making, allowing companies to reallocate resources towards the most effective initiatives for business growth and efficiency.
